Emre Kose and Kirti Prakash coding at the computer in the Integrated Pathology Unit (IPU)

The Royal Marsden NHS Foundation Trust

The Royal Marsden opened its doors in 1851 as the world’s first hospital dedicated to cancer diagnosis, treatment, research and education.

Today, together with its academic partner, The Institute of Cancer Research (ICR), it is one of the largest comprehensive cancer centres in Europe, seeing and treating over 60,000 NHS and private patients every year.  It is a centre of excellence with an international reputation for groundbreaking research and pioneering the very latest in cancer treatments and technologies.

The Royal Marsden, with the ICR, is the only National Institute for Health Care Research (NIHR) Biomedical Research Centre (BRC) in the UK dedicated solely to cancer. The specific remit of the BRC is to facilitate rapid and effective translation of scientific findings into improved therapies that are ultimately tested in large-scale national and international trials and subsequently influence clinical practice.

Find out more

The Royal Marsden Cancer Charity

The Royal Marsden Cancer Charity raises money solely to support The Royal Marsden, a world-leading cancer centre.  It ensures Royal Marsden nurses, doctors and research teams can provide the very best care and develop life-saving treatments, which are used across the UK and around the world.

The Charity’s support is vital in keeping the hospital at the forefront of its field. From funding state-of-the-art equipment and ground-breaking research, to creating the very best patient environments, The Royal Marsden Cancer Charity will never stop looking for ways to improve the lives of people affected by cancer.

Find out more

The Institute of Cancer Research, London

The Institute of Cancer Research (ICR), London, is one of the UK’s leading higher education institutions, placing first for biological sciences and second overall in the definitive ‘REF2021’ rankings of UK university research quality, impact and environment. Around 800 scientists work at the ICR across the full spectrum of cancer research, from basic cancer biology and drug discovery to clinical trials.

The ICR is consistently ranked by international league tables as one of the world’s most successful higher education institutions for effective collaboration with industry and has more than 100 active partnerships with a range of companies, from small, specialised biotech and medtech firms, to big pharma. It is the world’s most successful academic institution at discovering new cancer drugs, discovering 21 drug candidates since 2005, of which 11 have progressed into clinical development – many in partnership with The Royal Marsden NHS Foundation Trust, which are together ranked in the top four centres for cancer research and treatment worldwide and which in partnership lead one of the world’s leading oncology-focused phase I trial units.

Find out more